Click on a filter below to refine your search. Remove a filter to broaden your search.
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Developing AKI was associated with a significantly increased rate of subsequent dementia; the pattern was consistent across dementia types.
The estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults.
Homebound status linked to increased odds of ED visit, inpatient admission, skilled nursing-facility admission, mortality
The findings were seen specifically for the components of purpose in life and personal growth.
The ADRD-specific diagnosis intensity varies most for Black, Hispanic and youngest subgroups.
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
The median time to dementia was 15 years in the Penn cohort; the estimated probability of dementia at year 10 was 9 to 15% in the PPMI cohort.
Certain clinical features may identify those who may be in the prodromal phase of Parkinson’s disease.
The greatest reduction was seen for women aged 65 to 74 years who self-identify as Black.